BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37979962)

  • 1. Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entries.
    Mougel G; Mohamed A; Burnichon N; Giraud S; Pigny P; Bressac-de Paillerets B; Mirebeau-Prunier D; Buffet A; Savagner F; Romanet P; Arlot Y; Gardie B; Gimenez-Roqueplo AP; Beroud C; Richard S; Barlier A
    J Med Genet; 2024 Mar; 61(4):378-384. PubMed ID: 37979962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population.
    Romanet P; Mohamed A; Giraud S; Odou MF; North MO; Pertuit M; Pasmant E; Coppin L; Guien C; Calender A; Borson-Chazot F; Béroud C; Goudet P; Barlier A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):753-764. PubMed ID: 30339208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
    Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results.
    Rana HQ; Koeller DR; Schwartz A; Manning DK; Schneider KA; Krajewski KM; Choueiri TK; Lindeman NI; Garber JE; Ghazani AA
    Eur J Med Genet; 2021 Dec; 64(12):104359. PubMed ID: 34628056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
    Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
    Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
    Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
    J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
    Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
    BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations in the new E1' cryptic exon of the
    Buffet A; Calsina B; Flores S; Giraud S; Lenglet M; Romanet P; Deflorenne E; Aller J; Bourdeau I; Bressac-de Paillerets B; Calatayud M; Dehais C; De Mones Del Pujol E; Elenkova A; Herman P; Kamenický P; Lejeune S; Sadoul JL; Barlier A; Richard S; Favier J; Burnichon N; Gardie B; Dahia PL; Robledo M; Gimenez-Roqueplo AP
    J Med Genet; 2020 Nov; 57(11):752-759. PubMed ID: 31996412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.
    Vibert R; Lahlou-Laforêt K; Samadi M; Krivosic V; Blanc T; Amar L; Burnichon N; Abadie C; Richard S; Gimenez-Roqueplo AP
    Eur J Hum Genet; 2022 Oct; 30(10):1171-1177. PubMed ID: 35918537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease.
    Chiorean A; Farncombe KM; Delong S; Andric V; Ansar S; Chan C; Clark K; Danos AM; Gao Y; Giles RH; Goldenberg A; Jani P; Krysiak K; Kujan L; Macpherson S; Maher ER; McCoy LG; Salama Y; Saliba J; Sheta L; Griffith M; Griffith OL; Erdman L; Ramani A; Kim RH
    Hum Mutat; 2022 Sep; 43(9):1268-1285. PubMed ID: 35475554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial and genetic researches on three Chinese families with von Hippel-Lindau disease.
    Mao XC; Su ZP; Yu WQ; Zheng WM; Zeng YJ
    Neurol Res; 2009 Sep; 31(7):743-7. PubMed ID: 19133167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlation in ocular von Hippel-Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype.
    Mettu P; Agrón E; Samtani S; Chew EY; Wong WT
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4464-70. PubMed ID: 20375333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition.
    Binderup ML; Bisgaard ML; Harbud V; Møller HU; Gimsing S; Friis-Hansen L; Hansen Tv; Bagi P; Knigge U; Kosteljanetz M; Bøgeskov L; Thomsen C; Gerdes AM; Ousager LB; Sunde L;
    Dan Med J; 2013 Dec; 60(12):B4763. PubMed ID: 24355456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
    Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
    Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations.
    Ruiz-Llorente S; Bravo J; Cebrián A; Cascón A; Pollan M; Tellería D; Letón R; Urioste M; Rodríguez-López R; de Campos JM; Muñoz MJ; Lacambra C; Benítez J; Robledo M
    Hum Mutat; 2004 Feb; 23(2):160-169. PubMed ID: 14722919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
    Hes FJ; van der Luijt RB
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
    Nesković G; Stanojević B; Palmar I; Dimitrijević B
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
    Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
    Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families.
    Zhang J; Huang Y; Pan J; Liu D; Zhou L; Xue W; Chen Q; Dong B; Xuan H
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1211-8. PubMed ID: 18446368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.